How Many Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)'s Analysts Are Bullish?

Share

Therefore 70% are positive. GW Pharmaceuticals had 19 analyst reports since August 13, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of JAZZ in report on Friday, July 14 with "Buy" rating. As per Friday, August 26, the company rating was upgraded by Numis Securities.

Analysts await GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) to report earnings on December, 4. Jefferies has "Buy" rating and €192 target. Cowen & Co maintained GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) rating on Monday, September 25. Dekabank Deutsche Girozentrale, a Germany-based fund reported 59,557 shares. As per Wednesday, June 29, the company rating was initiated by BMO Capital Markets. On Friday, August 25 the stock rating was maintained by Robert W. Baird with "Hold". Mizuho maintained it with "Neutral" rating and $124 target in Wednesday, February 24 report. RBC Capital Markets maintained Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) on Tuesday, June 27 with "Buy" rating.

Jhl Capital Group Llc increased Makemytrip Limited Mauritius (MMYT) stake by 32.48% reported in 2017Q2 SEC filing. Moreover, Rk Capital Management Llc has 3.04% invested in the company for 97,224 shares.

The stock decreased 1.03% or Euro 2.7 on October 13, reaching Euro 260.65. It has outperformed by 15.20% the S&P500.The move comes after 7 months negative chart setup for the $2.83 billion company. (NYSE:MAIN) by 8,355 shares to 1.71M shares, valued at $65.85M in 2017Q2, according to the filing.

IPU 137th Assembly: Senate delegation leaves for Russian Federation
The speaker of the Duma lower house of Russia's parliament, Vyacheslav Volodin , said that he will visit Tehran next year. Others include Reps Samuel Ikon, Nnanna Igbokwe, Abubakar Fulata and Funke Adedoyin while advisers on the team are Sen.

Several other institutional investors and hedge funds also recently modified their holdings of JAZZ. Ericsson (NASDAQ:ERIC) was reduced too. The stock of Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) earned "Buy" rating by SunTrust on Thursday, June 2. Therefore 0 are positive. As per Monday, October 2, the company rating was maintained by Leerink Swann. On Monday, August 7 the stock rating was maintained by RBC Capital Markets with "Buy". On Thursday, October 13 the stock rating was upgraded by Goldman Sachs to "Buy". The stock of Embraer SA (ADR) (NYSE:ERJ) has "Outperform" rating given on Tuesday, October 18 by Cowen & Co. The firm has "Buy" rating given on Monday, September 26 by Cantor Fitzgerald. RBC Capital Markets maintained Embraer SA (ADR) (NYSE:ERJ) on Monday, May 2 with "Sector Perform" rating. About 12,771 shares traded or 77.35% up from the average. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has risen 31.90% since October 13, 2016 and is uptrending. It has underperformed by 15.45% the S&P500.

Among 28 analysts covering BB&T Corp (NYSE:BBT), 9 have Buy rating, 1 Sell and 18 Hold. Vetr downgraded shares of Jazz Pharmaceuticals plc - from a "strong-buy" rating to a "buy" rating and set a $161.19 target price on the stock.in a research report on Monday, March 27th. Also, EVP Michael Patrick Miller sold 200 shares of the business's stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $153.47, for a total value of $4,604,100.00. Manufacturers Life Insur The holds 0% of its portfolio in Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) for 357 shares.

Investors sentiment increased to 1.39 in 2017 Q2. Its up 0.05, from 1.11 in 2017Q1.

More recent Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) news were published by: Benzinga.com which released: "Jazz Pharma Investors: Did You Catch This Favorable Ruling?" on April 13, 2016. 51 funds opened positions while 102 raised stakes. The institutional investor held 8.36 million shares of the major banks company at the end of 2017Q2, valued at $379.41 million, up from 8.08 million at the end of the previous reported quarter. The specialty pharmaceutical company reported $1.41 EPS for the quarter, missing the Zacks' consensus estimate of $1.42 by $0.01. Burgundy Asset Ltd reported 8.36M shares stake. $750,000 worth of Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) was sold by Winningham Rick E on Thursday, June 1. World Asset Management Inc raised its holdings in shares of Jazz Pharmaceuticals PLC by 1.9% during the second quarter. Deutsche Bank maintained Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ) rating on Wednesday, August 9. Ww Asset Management Inc accumulated 0.01% or 1,441 shares. The company was initiated on Thursday, August 13 by Morgan Stanley. Susquehanna Interest Grp Inc Llp holds 0% or 11,881 shares. "(NASDAQ:IMGN) and Jazz Pharmaceuticals plc â€" Ordinary Shares ..." on September 08, 2017. (NASDAQ:STRA) by 3,736 shares in the quarter, leaving it with 330,997 shares, and cut its stake in Marketaxess Holdings Inc. Following the sale, the chief executive officer now directly owns 296,418 shares of the company's stock, valued at approximately $45,491,270.46.

Share